CymitQuimica logo

CAS 1130115-44-4

:

Sorafenib-d3

Description:
Sorafenib-d3 is a deuterated form of Sorafenib, a multi-kinase inhibitor primarily used in the treatment of certain cancers, including renal cell carcinoma and hepatocellular carcinoma. The "d3" designation indicates that this compound contains three deuterium atoms, which are isotopes of hydrogen, replacing the regular hydrogen atoms in the molecule. This modification can enhance the stability and tracking of the compound in metabolic studies. Sorafenib itself works by inhibiting various kinases involved in tumor growth and angiogenesis, thereby impeding cancer progression. The deuterated version is often utilized in pharmacokinetic studies to better understand the drug's behavior in biological systems. Sorafenib-d3 retains similar pharmacological properties to its non-deuterated counterpart, making it a valuable tool in research settings. Its molecular structure includes a pyridine ring and a urea moiety, contributing to its activity against specific targets in cancer cells. Overall, Sorafenib-d3 serves as an important compound in both therapeutic applications and scientific research.
Formula:C21H16ClF3N4O3
Synonyms:
  • [2H3]-Sorafenib
  • SORAFENIB D3 (BAY 43-9006 D3)
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(trideuteriomethyl)pyridine-2-carboxamide
  • Donafenib Tosylate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.